SELECTBIO and the Diagnostics Development Hub, part of Exploit Technologies Pte. Ltd. present Singapore's inaugural Diagnostics Summit – Circulating Biomarkers for Liquid Biopsies and Companion Diagnostics
The full event Agenda is now live and we look forward to welcoming the world's leading experts to Singapore. To view the full AGENDA please follow the link below.
With 40 international speakers, this comprehensive event will provide a detailed overview of; the current research, the latest innovations, the regulatory requirements, commercialisation of diagnostic innovations and market entry into Asia.
Offering key networking opportunities with the leading international researchers, regulators, innovators and solution providers. We will address the unmet clinical needs and also help entrepreneurs and researchers accelerate the transformation of their IPs into clinically validated diagnostic devices.
Guest of Honour
• Lim Chuan Poh, Chairman, A*STAR
Plenary Speakers
• Jean-Luc Butel, Senior Advisor, McKinsey & Company, President,K8 Global
• Chwee Teck Lim, Provost's Chair Professor, National University of Singapore
• Fred Kramer, Professor, New Jersey Medical School Rutgers University
• Rudi Pauwels, Founder Director/Chief Executive Officer, Biocartis
• Steve Myint, Senior Fellow, A*STAR, Adjunct Professor, Duke-NUS
We are offering 3 for 2 on ALL conference passes and with prices starting at only S$399 for Academics and Clinicians and only S$499 for Industry participants, this is a not to be missed event.
For further details on the event, including sponsorship opportunities or group bookings please contact me directly.
Thanks and we hope you can join us.
Paul Raggett
CEO
Select Biosciences South East Asia Pte. Ltd.
16 Raffles Quay, #33-03 Hong Leong Building,
Singapore 048581
+65 8525 9814
+855 6999 5137
[email protected]
